全文获取类型
收费全文 | 245130篇 |
免费 | 19255篇 |
国内免费 | 7810篇 |
专业分类
耳鼻咽喉 | 2041篇 |
儿科学 | 7981篇 |
妇产科学 | 1762篇 |
基础医学 | 20981篇 |
口腔科学 | 3996篇 |
临床医学 | 26500篇 |
内科学 | 59894篇 |
皮肤病学 | 3078篇 |
神经病学 | 27405篇 |
特种医学 | 6786篇 |
外国民族医学 | 4篇 |
外科学 | 19247篇 |
综合类 | 35405篇 |
现状与发展 | 31篇 |
一般理论 | 10篇 |
预防医学 | 18906篇 |
眼科学 | 2480篇 |
药学 | 18279篇 |
205篇 | |
中国医学 | 12803篇 |
肿瘤学 | 4401篇 |
出版年
2024年 | 244篇 |
2023年 | 4730篇 |
2022年 | 6662篇 |
2021年 | 12064篇 |
2020年 | 11943篇 |
2019年 | 9203篇 |
2018年 | 9099篇 |
2017年 | 9097篇 |
2016年 | 9616篇 |
2015年 | 9318篇 |
2014年 | 18109篇 |
2013年 | 19378篇 |
2012年 | 14936篇 |
2011年 | 16188篇 |
2010年 | 12747篇 |
2009年 | 12064篇 |
2008年 | 11883篇 |
2007年 | 11563篇 |
2006年 | 10277篇 |
2005年 | 8469篇 |
2004年 | 7117篇 |
2003年 | 6125篇 |
2002年 | 5093篇 |
2001年 | 4439篇 |
2000年 | 3670篇 |
1999年 | 3118篇 |
1998年 | 2716篇 |
1997年 | 2319篇 |
1996年 | 2090篇 |
1995年 | 2137篇 |
1994年 | 1987篇 |
1993年 | 1681篇 |
1992年 | 1599篇 |
1991年 | 1411篇 |
1990年 | 1155篇 |
1989年 | 988篇 |
1988年 | 920篇 |
1987年 | 828篇 |
1986年 | 708篇 |
1985年 | 827篇 |
1984年 | 713篇 |
1983年 | 440篇 |
1982年 | 521篇 |
1981年 | 424篇 |
1980年 | 360篇 |
1979年 | 304篇 |
1978年 | 223篇 |
1977年 | 209篇 |
1976年 | 168篇 |
1974年 | 67篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
61.
62.
63.
64.
65.
66.
67.
《Archivos de bronconeumología》2022,58(1):11-21
BackgroundWe aimed to describe the effectiveness and safety of inhaled antibiotics in chronic obstructive pulmonary disease (COPD) patients, as well as the patient profile in which they are usually prescribed and the patient groups that can most benefit from this treatment.MethodsMulticentre retrospective observational cohort study in COPD patients who had received ≥1 dose of inhaled antibiotics in the last 5 years. Clinical data from the two years prior to and subsequent to the start of the treatment were compared. Primary outcome: COPD exacerbations. Secondary outcomes: side effects, symptomatology (sputum purulence, dyspnoea), microbiological profile and pathogen eradication.ResultsOf 693 COPD patients analyzed (aged 74.1; 86.3% men; mean FEV1 = 43.7%), 71.7% had bronchiectasis and 46.6% presented chronic bronchial infection (CBI) by Pseudomonas aeruginosa (PA). After 1 year of treatment with inhaled antibiotics, there was a significant decrease in the number of exacerbations (?33.3%; P < .001), hospital admissions (?33.3%; P < .001) and hospitalization days (?26.2%; P = .003). We found no difference in effectiveness between patients with or without associated bronchiectasis. Positive patient outcomes were more pronounced in PA-eradicated patients. We found a significant reduction in daily expectoration (?33.1%; P = .024), mucopurulent/purulent sputum (?53.9%; P < .001), isolation of any potentially pathogenic microorganisms (PPM) (?16.7%; P < .001), CBI by any PPM (?37.4%; P < .001) and CBI by PA (?49.8%; P < .001). CBI by any PPM and ≥three previous exacerbations were associated with a better treatment response. 25.4% of patients presented non-severe side-effects, the most frequent of these being bronchospasm (10.5%), dyspnoea (8.8%) and cough (1.7%).ConclusionsIn COPD patients with multiple exacerbations and/or CBI by any PPM (especially PA), inhaled antibiotics appear to be an effective and safe treatment, regardless of the presence of bronchiectasis. 相似文献
68.
Glaucoma is a leading cause of irreversible blindness. The use of topical eye drops to reduce intraocular pressure remains the mainstay treatment. These eye drops frequently contain preservatives designed to ensure sterility of the compound. A growing number of clinical and experimental studies report the detrimental effects of not only these preservatives but also the active pharmaceutical compounds on the ocular surface, with resultant tear film instability and dry eye disease. Herein, we critically appraise the published literature exploring the effects of preservatives and pharmaceutical compounds on the ocular surface. 相似文献
69.
A 25-year-old, emaciated man without medical treatment was found to have died suddenly at home by his mother. At autopsy, there were no injuries to his body, but significant circulatory insufficiency was observed. Electron microscopy revealed abnormal mitochondria in cells of the cardiac conduction system. The conduction system was filled with mitochondrial size abnormalities and mitochondrial cristae abnormalities. No notable abnormal findings were observed in other organs. Genetic examination of the blood revealed the mitochondrial pathogenetic variant m.3243A>G. Epileptic seizures, diabetic ketoacidosis, and hyperosmolar hyperglycemic state were unlikely to be the cause of sudden death. The cause of death was diagnosed as arrhythmia possibly induced by the failure of the cardiac conduction system due to mitochondrial disease. This is a rare case of sudden death caused by an accumulation of abnormal mitochondria in the cardiac conduction system. 相似文献
70.
目的 通过网络药理学的方法进行预测,再深一步进行动物实验验证来研究柴胡疏肝散治疗CAG的作用机制。方法 首先在TCMSP数据库中检索柴胡疏肝散的所有活性成分与药物靶点;通过收集PharmGkb、OMIM、GeneCards和DrugBank数据库中收录的慢性萎缩性胃炎的相关靶点。将药物靶点与疾病靶点进行映射筛选出交集靶点,将得到的交集靶点构建PPI网络与活性成分-共同靶点网络,并对其进行GO和KEGG富集分析。最后利用Vina软件进行分子对接实验验证,并通过免疫印迹法验证柴胡疏肝散对两种受体蛋白EGFR和STAT1的影响。结果 最终筛选得到柴胡疏肝散活性成分104个,潜在靶点238个,与慢性萎缩性胃炎的交集靶点52个;GO与KEGG富集分析分别得到2166条目和148条目,主要涉及到JAK-STAT信号通路、TNF信号通路、HIF-1信号通路等;分子对接结果显示EGFR、STAT1两个靶点能够与核心活性成分能够自发结合成较为稳定的构像;免疫印迹法实验证明柴胡疏肝散能够降低大鼠胃黏膜组织EGFR和STAT1蛋白表达。结论 通过网络药理学和实验验证,发现柴胡疏肝散可能通过调节EGFR和STAT1蛋白表达来共同调控胃黏膜细胞增殖与凋亡,进而发挥着治疗慢性萎缩性胃炎的效果,为深入进行柴胡疏肝散治疗慢性萎缩性胃炎的作用机制研究提供新思路和新方法。 相似文献